NovaBridge Biosciences
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2019 | — | -4,830.1% | -4,840.1% |
| FY2020 | — | 31.4% | 30.5% |
| FY2021 | 47.3% | -2,652.3% | -2,648.7% |
| FY2022 | 354.6% | 3,422.2% | 23,923.5% |
| FY2023 | — | -11,395.1% | -32,868.5% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2019 | — | -4,830.1% | -4,840.1% |
| FY2020 | — | 31.4% | 30.5% |
| FY2021 | 47.3% | -2,652.3% | -2,648.7% |
| FY2022 | 354.6% | 3,422.2% | 23,923.5% |
| FY2023 | — | -11,395.1% | -32,868.5% |